News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,819 Results
Type
Article (32569)
Company Profile (63)
Press Release (251180)
Multimedia
Podcasts (83)
Webinars (11)
Section
Business (91208)
Career Advice (1160)
Deals (16236)
Drug Delivery (127)
Drug Development (39150)
Employer Resources (189)
FDA (7615)
Job Trends (7699)
News (139603)
Policy (14111)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (3)
Academia (1861)
Accelerated approval (35)
ADA (21)
Adcomms (17)
Allergies (90)
Alliances (15645)
ALS (99)
Alzheimer's disease (895)
Antibody-drug conjugate (ADC) (263)
Approvals (8046)
Artificial intelligence (323)
ASCO (174)
Autoimmune disease (183)
Automation (21)
Bankruptcy (137)
Belgium (1)
Best Places to Work (5595)
BIO (29)
Biologics (4)
BIOSECURE Act (11)
Biosimilars (161)
BioSpace Insights (96)
Biotechnology (45)
Bladder cancer (123)
Brain cancer (47)
Breast cancer (393)
Cancer (3148)
Cardiovascular disease (247)
Career advice (1016)
Career pathing (19)
CAR-T (180)
CDC (22)
CDMO (99)
Celiac Disease (2)
Cell therapy (414)
Cervical cancer (31)
Clinical research (34273)
Collaboration (792)
Commercialization (2)
Company closure (2)
Compensation (429)
Complete response letters (45)
COVID-19 (2388)
CRISPR (44)
C-suite (549)
Cystic fibrosis (74)
Data (4490)
Denatured (28)
Depression (69)
Dermatology (61)
Diabetes (316)
Diagnostics (2966)
Digital health (31)
Diversity (6)
Diversity, equity & inclusion (47)
Drug discovery (140)
Drug pricing (104)
Drug shortages (14)
Duchenne muscular dystrophy (141)
Earnings (40603)
Editorial (25)
Employer branding (24)
Employer resources (157)
Events (37858)
Executive appointments (508)
FDA (9743)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (11)
Frontotemporal dementia (17)
Funding (668)
Gene editing (106)
Generative AI (28)
Gene therapy (341)
GLP-1 (829)
Government (2879)
Grass and pollen (3)
Guidances (346)
Healthcare (8421)
Hematology (93)
HIV (65)
Huntington's disease (33)
IgA nephropathy (79)
Immunology and inflammation (110)
Immuno-oncology (49)
Indications (127)
Infectious disease (2531)
Inflammatory bowel disease (115)
Inflation Reduction Act (9)
Influenza (59)
Intellectual property (100)
Interviews (237)
IPO (8898)
IRA (32)
Job creations (2244)
Job search strategy (801)
JPM (34)
Kidney cancer (16)
Labor market (56)
Layoffs (526)
Leadership (19)
Legal (2771)
Licensing (9)
Liver cancer (63)
Longevity (10)
Lung cancer (513)
Lymphoma (322)
Machine learning (16)
Management (59)
Manufacturing (516)
Marketing (7)
MASH (120)
Medical affairs (2)
Medical device (5775)
Medtech (5854)
Mergers & acquisitions (7868)
Metabolic disorders (884)
mRNA (182)
Multiple sclerosis (132)
NASH (20)
Netherlands (1)
Neurodegenerative disease (192)
Neuropsychiatric disorders (41)
Neuroscience (1701)
Neurotech (1)
NextGen: Class of 2026 (3037)
Non-profit (1799)
Now hiring (56)
Obesity (428)
Opinion (261)
Ovarian cancer (125)
Pain (114)
Pancreatic cancer (153)
Parkinson's disease (169)
Partnered (13)
Patents (242)
Patient recruitment (323)
Patient selection (1)
Peanut (29)
People (22968)
Peptides (2)
Pharmaceutical (12)
Pharmacy benefit managers (19)
Phase 1 (9343)
Phase 2 (14955)
Phase 3 (13835)
Pipeline (6148)
Policy (124)
Postmarket research (1137)
Preclinical (3023)
Press Release (37)
Prostate cancer (169)
Psychedelics (26)
Radiopharmaceuticals (144)
Rare diseases (585)
Real estate (2416)
Recruiting (71)
Regulatory (11443)
Reports (54)
Research institute (1490)
Resumes & cover letters (188)
Rett syndrome (25)
RNA editing (14)
RSV (43)
Schizophrenia (111)
Series A (119)
Series B (72)
Service/supplier (3)
Sickle cell disease (72)
Special edition (16)
Spinal muscular atrophy (102)
Sponsored (41)
Startups (1815)
State (1)
Stomach cancer (7)
Supply chain (41)
Tariffs (31)
The Weekly (54)
Vaccines (803)
Venture capital (47)
Weight loss (318)
Women's health (60)
Worklife (14)
Date
Last 7 days (223)
Last 30 days (829)
Last 365 days (12819)
2026 (9166)
2025 (12370)
2024 (15065)
2023 (17603)
2022 (26794)
2021 (28465)
2020 (25465)
2019 (22770)
2018 (16324)
2017 (13273)
2016 (11546)
2015 (13821)
2014 (9518)
2013 (6714)
2012 (7227)
2011 (7813)
2010 (6658)
Location
Africa (419)
Alabama (32)
Alaska (1)
Arizona (119)
Arkansas (5)
Asia (19445)
Australia (3046)
California (5631)
Canada (1670)
China (830)
Colorado (279)
Connecticut (281)
Delaware (258)
Europe (47432)
Florida (758)
Georgia (176)
Hawaii (2)
Idaho (11)
Illinois (548)
India (68)
Indiana (332)
Iowa (7)
Japan (334)
Kansas (83)
Kentucky (25)
Louisiana (29)
Maine (27)
Maryland (680)
Massachusetts (4146)
Michigan (120)
Minnesota (264)
Mississippi (4)
Missouri (66)
Montana (11)
Nebraska (6)
Nevada (72)
New Hampshire (51)
New Jersey (1897)
New Mexico (9)
New York (1708)
North Carolina (740)
North Dakota (1)
Northern California (2995)
Ohio (173)
Oklahoma (9)
Oregon (15)
Pennsylvania (1079)
Puerto Rico (15)
Rhode Island (22)
South America (549)
South Carolina (68)
Southern California (2244)
Tennessee (96)
Texas (910)
United States (20716)
Utah (172)
Vermont (1)
Virginia (114)
Washington D.C. (23)
Washington State (401)
West Virginia (2)
Wisconsin (54)
Wyoming (1)
283,819 Results for "20".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
• Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenue • Positions BioHarvest in sustainable rare luxury fragrance manufacturing • BioHarvest to target additional collaborations in the high-margin rare fragrance space
August 11, 2026
·
7 min read
Press Releases
INOVIO Announces Pricing of $20.0 Million Public Offering
July 29, 2026
·
4 min read
Press Releases
Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site
August 5, 2026
·
3 min read
Press Releases
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
August 17, 2026
·
16 min read
Press Releases
Savara Announces New Employment Inducement Grant - August 20, 2026
August 20, 2026
·
2 min read
Press Releases
Qureight Closes $20 Million Series B Financing
July 29, 2026
·
3 min read
Press Releases
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
September 10, 2026
·
4 min read
Press Releases
Legionella present in nearly 20% of water samples, new test results found
September 3, 2026
·
4 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - July 20, 2026
July 20, 2026
·
2 min read
Press Releases
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
August 27, 2026
·
7 min read
1 of 28,382
Next
